Pα+ Psychedelic Bulletin #160: Mutual Recognition for MDMA-AT in the UK? Beckley Shares Cut of 5-MeO-DMT Data; and more
- A Look at Potential Mutual Recognition of FDA Approval for Psychedelics Via the UK MHRA’s International Recognition Procedure
- Beckley Psytech Shares Topline Data from Phase 2a Study of 5-MeO-DMT for TRD
- Other News
- In Case You Missed It
Companies, organisations and drug candidates mentioned in this Bulletin: Lykos Therapeutics, MDMA-assisted therapy; Compass Pathways; COMP360; MHRA; Beckley Psytech; BPL-003; GH Research; GH001; Numinus; PharmAla Biotech; NIDA; MindBio...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In